Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and duloxetine for idiopathic chronic pelvic pain in women
IRCT20260213068845N2Phase 3Recruiting
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of pregabalin and duloxetine in chronic prostatitis (CP) (4 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Change in chronic pelvic pain intensity. Started Jul 2026; status: recruiting.
02
Drugs
pregabalinduloxetine
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on IRCT20260213068845N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260213068845N2.